Postoperative nomogram for predicting disease-specific death and recurrence in papillary thyroid carcinoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 26332104.
- Also identified by DOI 10.1002/hed.24201.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A nomogram could provide individualized prognostic for papillary thyroid carcinoma (PTC). The purpose of our study was to develop and validate a new nomogram. Consecutive patients with PTC from 2 different institutions were analyzed and divided into the development (n = 849) and validation (n = 275) sets. The former was used for formulating a nomogram in predicting disease-specific death and recurrence, whereas the latter was for validation (by area under the curve [AUC]). The nomogram had excellent discrimination in predicting 10-year disease-specific death and recurrence (0.984; 0.969-0.998; and 0.743; 0.658-0.828; respectively). A score <30 meant 100% of the patients survived at 10 years and those who died within 10 years had a score ≥30. A score <17 meant almost all the patients (91.04%) were disease-free within 10 years. Using a competing-risk model, a nomogram was created with excellent discriminatory ability and accuracy in predicting 10-year disease-specific death and recurrence for PTC. Our results implied its potential for wider use in other populations. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1256-E1263, 2016.
Medical subject headings
- Carcinoma, Papillary
- Neoplasm Recurrence, Local
- Nomograms
- Thyroid Neoplasms